Skip to content

A study of intestinal flora and changes in inflammation levels and cognitive function in insomnia patients with different objective sleep duration

A study of intestinal flora and changes in inflammation levels and cognitive function in insomnia patients with different objective sleep duration

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065385
Enrollment
Unknown
Registered
2022-11-03
Start date
2022-11-03
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Ia-1:Probiotic
Ia-2:Placebo

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Case group inclusion criteria: (1) Patients with primary insomnia disorder who met the ICSD-3 diagnostic criteria; (2) Aged 18-45 years, with approximately the same number of men and women; (3) Han Chinese; (4) Voluntary participation in the study and signed informed consent; (5) The diet is basically the same and stable; (6) Stable sleep rhythm every night for 2 weeks prior to enrolment. 2. Inclusion criteria for the control group: (1) Physically healthy; (2) Aged 18-45 years, with about the same number of men and women; (3) Han Chinese; (4) Voluntary participation in the study and signed informed consent; (5) Basic and stable dietary structure; (6) Regular work and rest, good sleep and hygiene habits.

Exclusion criteria

Exclusion criteria: 1. Current co-morbidity with other psychiatric and behavioural disorders or neurological disorders with cognitive dysfunction; 2. Undergoing or receiving any psychological or psychotropic medication within 3 weeks prior to enrollment; 3. Concomitant somatic disorders of the heart, liver, kidney, brain or gastrointestinal tract or with chronic pain; 4. Are using, or have used within 3 weeks prior to enrolment, antibiotics, anti-inflammatory drugs, probiotics, prebiotics, synbiotics, co-biotics or acid suppressants; 5. Women who are menstruating, planning a pregnancy, or in pregnancy or breastfeeding; 6. Malnutrition or obesity (BMI = 30); 7. consuming tobacco, alcohol, caffeine or other stimulants at bedtime or within 3 weeks prior to enrolment; 8. Consistent smoking >= 1 cigarette/day or consistent alcohol consumption >= 1 drink/week in the last 6 months; 9. Known active bacterial, fungal or viral infection; 10. Being or working on jet lag or shifts or experiencing other psychological stress and stressful events within 3 weeks prior to entry; 11. Are participating in sleep deprivation or related research studies or within 3 weeks prior to enrollment.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;Inflammatory factor;Cognitive function;

Countries

China

Contacts

Public ContactYumei Wang

The First Hospital of Hebei Medical University

wangyumei19771021@hotmail.com+86 18633889983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026